Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally
2011 ◽
Vol 52
(6)
◽
pp. 1200-1210
◽
1979 ◽
Vol 27
(9)
◽
pp. 1283-1284
◽
1986 ◽
Vol 64
(5)
◽
pp. 656-660
◽
1992 ◽
Vol 115
(3)
◽
pp. 388-393
◽
1964 ◽
Vol 119
(6)
◽
pp. 869-879
◽
Keyword(s):
1991 ◽
pp. 289-299
◽
2010 ◽
Vol 38
(6)
◽
pp. 1424-1431
◽
1977 ◽
Vol 35
◽
pp. 352-353
Keyword(s):